Thank you for the break down.
So they are drilling in the pilbara, awaiting environemental consent in Canada and they already have a non-binding offtake agreement with a Chinese producer.
James Brown from Altura is heading this project after already getting Altura to production and it looks as if he/they want to sell Altura and have SYA as their next project in the works. I am of the opinion that Pilabara Minerals will buy Altura as it is sitting right next to them, they need/are going to build a second plant and they have the $ to do it.
It's a pretty good looking stock at present, but there are road blocks in the way - the most considerable of which is the environmental permitting and the village near the specified resource they want to mine. I'm sure the French Canadians are a vocal bunch too and wont let them mine without a fight.
Hope I am wrong though and they just have to mine it with stringent envornmental controls in place.
The stock price should increase dramatically once drill results start to come thru, environmental consent gets approved and their non-binding agreement with the Chinese becomes binding.
Anything else I am missing here?
The main key to the whole equation for me is James Brown and the fact that he and his team has already been able to do what they have at Altura/Pilgangoora. I believe that SYA is AJM v2.0 and they already have a deep understanding of what they need to do to get the dirt out of the ground and onto the port.
Been sitting on the sidelines too long, need to get on the bus and buy some before it all comes together.
- Forums
- ASX - By Stock
- SYA
- Ann: Company Presentation Noosa Mining Conference
Ann: Company Presentation Noosa Mining Conference, page-53
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SYA (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.4¢ |
Change
0.002(6.25%) |
Mkt cap ! $349.9M |
Open | High | Low | Value | Volume |
3.3¢ | 3.6¢ | 3.3¢ | $1.008M | 29.35M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 7404228 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 5652958 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 7304228 | 0.034 |
30 | 10564163 | 0.033 |
52 | 10046330 | 0.032 |
32 | 9673934 | 0.031 |
56 | 10254739 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 5652958 | 20 |
0.036 | 15684373 | 35 |
0.037 | 11414857 | 36 |
0.038 | 15156283 | 31 |
0.039 | 8468058 | 17 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
SYA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online